Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.

Latest updates to the Tepotinib Phase II Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed. Overall, a minor maintenance update with no substantive changes to core content, pricing, or stock.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on cancer treatments and clinical trials, particularly focusing on tepotinib for non-small cell lung cancer. Several previous entries related to locations and cancer types have been removed.SummaryDifference17%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe webpage has updated its version from v2.16.11 to v2.16.12 and has removed several past dates from 2024 while adding new dates in August 2025.SummaryDifference0.4%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.